Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
PXR, or pregnane X receptor, is also known as the pregnane activated receptor (PAR) or the steroid and xenobiotic receptor (SXR). The majority of recent literature uses the name PXR, and hence this convention is followed herein.
- 2.
AREs are also known as electrophile responsive elements, or EpREs.
References
Albano, E., Rundgren, M., Harvison, P. J., Nelson, S. D., and Moldeus, P. 1985. Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity. Mol. Pharmacol. 28:306–311.
Aninat, C., Piton, A., Glaise, D., Le Charpentier, T., Langouet, S., Morel, F., Guguen-Guillouzo, C., and Guillouzo, A. 2006. Expression Of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab. Dispos. 34:75–83.
Bertilsson, G., Heidrich, J., Svensson, K., Asman, M., Jendeberg, L., Sydow-Backman, M., Ohlsson, R., Postlind, H., Blomquist, P., and Berkenstam, A. 1998. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc. Natl. Acad. Sci. USA 95:12208–12213.
Blumberg, B., Sabbagh Jr., W., Juguilon, H., Bolado Jr., J., van Meter, C. M., Ong, E. S., and Evans, R. M. 1998. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev. 12:3195–3205.
Boelsterli, U. A., and Goldlin, C. 1991. Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites. Arch. of Toxicol. 65:351–360.
Boelsterli, U. A., Lanzotti, A., Goldlin, C., and Oertle, M. 1992. Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes. Drug Metab. Dispos. 20:96–101.
Bornheim, L. 1998. Effect of cytochrome P450 inducers on cocaine-mediated hepatotoxicity. Toxicol. Appl. Pharmacol. 150:158–165.
Brown, R. R., Miller, J. A., and Miller, E. C. 1954. The metabolism of methylated aminoazo dyes. IV. Dietary factors enhancing demethylation in vitro. J. Biol. Chem. 209:211–222.
Castell, J. V., Jover, R., Martinez-Jimenez, C. P., and Gomez-Lechon, M. 2006. Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies. Expert Opin. Drug Metab. Toxicol. 2:183–212.
Chan, K., Han, X.-D., and Kan, Y. W. 2001. An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen. Proc. Natl. Acad. Sci. USA 98:4611–4616.
Cho, H.-Y., Jedlicka, A. E., Reddy, S. P. M., Kensler, T. W., Yamamoto, M., Zhang, L.-Y., and Kleeberger, S. R. 2002. Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 26:175–182.
Chojkier, M. 2005. Troglitazone and liver injury: In search of answers. Hepatology 41:237–246.
Ciolino, H. P., Daschner, P. J., and Yeh, G. C. 1998. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res. 58:5707–5712.
Conney, A. H. 1967. Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19:317–366.
Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J., and Diehl, J. A. 2003. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell. Biol. 23:7198–7209.
Dahlin, D. C., Miwa, G. T., Lu, A. Y. H., and Nelson, S. D. 1984. N-acetyl-p-benzoquinone imine: A cytochrome P450-mediated oxidation product of acetaminophen. Proc. Natl. Acad. Sci. USA 81:1327–1331.
Denison, M. S., and Nagy, S. R. 2003. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Ann. Rev. Pharmacol. Toxicol. 43:309–334.
Ding, X., Lichti, K., Kim, I., Gonzalez, F. J., and Staudinger, J. L. 2006. Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor {alpha}, and the coactivator peroxisome proliferator-activated receptor {gamma} coactivator-1{alpha}. J. Biol. Chem. 281:26540–26551.
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., and Talalay, P. 2002. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. USA 99:11908–11913.
Drocourt, L., Ourlin, J.-C., Pascussi, J.-M., Maurel, P., and Vilarem, M.-J. 2002. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J. Biol. Chem. 277:25125–25132.
Enomoto, A., Itoh, K., Nagayoshi, E., Haruta, J., Kimura, T., O'Connor, T., Harada, T., and Yamamoto, M. 2001. High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59:169–177.
Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., and Gonzalez, F. J. 1995. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268:722–726.
Forman, B. M., Tzameli, I., Choi, H.-S., Chen, J., Simha. D., Seol, W., Evans, R. M., and Moore, D. D. 1998. Androstane metabolites bind to and deactivate the nuclear receptor CAR-[beta]. Nature 395:612–615.
Galvan, N., Jaskula-Sztul, R., MacWilliams, P. S., Czuprynski, C. J., and Jefcoate, C. R. 2003. Bone marrow cytotoxicity of benzo[a]pyrene is dependent on CYP1B1 but is diminished by Ah receptor-mediated induction of CYP1A1 in liver. Toxicol. Appl. Pharmacol. 193:84–96.
Germain, P., Staels, B., Dacquet, C., Spedding, M., and Laudet, V. 2006. Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 58:685–704.
Gong, P., and Cederbaum, A. I. 2006. Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1. Hepatology 43:144–153.
Gonzalez, F. J. 2007. CYP2E1. Drug Metab. Dispos. 35:1–8.
Guillouzo, A., Corlu, A., Aninat, C., Glaise, D., Morel, F., and Guguen- Guillouzo, C. 2007. The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem.-Biol. Interact. 168:66–73.
Guo, G. L., Moffit, J. S., Nicol, C. J., Ward, J. M., Aleksunes, L. A., Slitt, A. L., Kliewer, S. A., Manautou, J. E., and Gonzalez, F. J. 2004. Enhanced acetaminophen toxicity by activation of the pregnane X receptor. Toxicol. Sci. 82:374–380.
Guzelian, J., Barwick, J. L., Hunter, L., Phang, T. L., Quattrochi, L. C., and Guzelian, P. S. 2006. Identification of genes controlled by the pregnane X receptor by microarray analysis of mRNAs from pregnenolone 16{alpha}- carbonitrile-treated rats. Toxicol. Sci. 94:379–387.
Hankinson, O. 2005. Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Arch. Biochem. Biophys. 433:379–386.
Hanlon, P. R., Zheng, W., Ko, A. Y., and Jefcoate, C. R. 2005. Identification of novel TCDD-regulated genes by microarray analysis. Toxicol. Appl. Pharmacol. 202:215–228.
Hastings, K. L. 2006. The use of hepatotoxic signals to predict the safety of peroxisome proliferator-activated receptor agonists. Expert Opinion on Drug Metab. Toxicol. 2:489–492.
Heidel, S. M., MacWilliams, P. S., Baird, W. M., Dashwood, W. M., Buters, J. T. M., Gonzalez, F. J., Larsen, M. C., Czuprynski, C. J., and Jefcoate, C. R. 2000. Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthracene. Cancer Res. 60:3454–3460.
Hewitt, N. J., Lloyd, S., Hayden, M., Butler, R., Sakai, Y., Springer, R., Fackett, A., and Li, A P. 2002. Correlation between troglitazone cytotoxicity and drug metabolic enzyme activities in cryopreserved human hepatocytes. Chem. Biol. Interact. 142:73–82.
Hinson, J. A., Reid, A. B., McCullough, S. S., and James, L. P. 2004. Acetaminophen-induced hepatotoxicity: Role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab. Rev. 36:805–822.
Hoensch, H. P., Balzer, K., Dylewizc, P., Kirch, W., Goebell, H., and Ohnhaus, E. E. 1985. Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. Eur. J. Clin. Pharmacol. 28:475–477.
Honkakoski, P., Zelko, I., Sueyoshi, T., and Negishi, M. 1998. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol. Cell. Biol. 18:5652–5658.
Huang, H. C., Nguyen, T., and Pickett, C. B. 2000. Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc. Natl. Acad. Sci. USA 97:12475–12480.
Huang, W., Zhang, J., Chua, S. S., Qatanani, M., Han, Y., Granata, R., and Moore, D. D. 2003. Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc. Natl. Acad. Sci. USA 100:4156–4161.
Huang, W., Zhang, J., Washington, M., Liu, J., Parant, J. M., Lozano, G., and Moore, D. D. 2005 Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol. Endocrinol. 19:1646–1653.
Huang, H., Wang, H., Sinz, M., Zoeckler, M., Staudinger, J., Redinbo, M. R., Teotico, D. G., Locker, J., Kalpana, G. V., and Mani, S. 2007. Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole. Oncogene 26:258–268.
Iida, K., Itoh, K., Kumagai, Y., Oyasu, R., Hattori, K., Kawai, K., Shimazui, T., Akaza, H., and Yamamoto, M. 2004. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res. 64:6424–6431.
Ioannides, C., and Parke, D. V. 1993. Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis. Drug Metab. Rev. 25:485–501.
Issemann, I., and Green S. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645–650.
Itoh, K., Chiba,T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M., and Nabeshima, Y.-I. 1997. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236:313–322.
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., and Yamamoto, M. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13:76–86.
James, L. P., Mayeux, P. R., and Hinson, J. A. 2003. Acetaminophen-induced hepatotoxicity. Drug Metab. Dispos. 31:1499–1506.
Javor, T., Gogl, A., Horvath, T., and Tenyi, I. 1973. Effects of phenobarbital treatment on biliary excretion in man. Drug Metab. Dispos. 1:424–427.
Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C. O., LeCluyse, E. L., Lambert, M. H., Willson, T. M., Kliewer, S. A., and Moore, J. T. 2000. The pregnane X receptor: A promiscuous xenobiotic receptor that has diverged during evolution. Mol. Endocrinol. 14:27–39.
Kassahun, K., Pearson, P. G., Tang, W., McIntosh, I., Leung, K., Elmore, C., Dean, D., Wang, R., Doss, G., and Baillie, T. A. 2001. Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. Chem. Res. Toxicol. 14:62–70.
Kawamoto, T., Sueyoshi, T., Zelko, I., Moore, R., Washburn, K., and Negishi, M. 1999. Phenobarbital-responsive nuclear tanslocation of the receptor CAR in induction of the CYP2B gene. Mol. Cell. Biol. 19:6318–6322.
Kliewer, S. A., Goodwin, B., and Willson, T. M. 2002. The nuclear pregnane X receptor: A key regulator of xenobiotic metabolism. Endocr. Rev. 23:687–702.
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterstrom, R. H., Perlmann, T., and Lehmann, J. M. 1998. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92:73–82.
Kobayashi, K., Sueyoshi, T., Inoue, K., Moore, R., and Negishi, M. 2003. Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Mol. Pharmacol. 64:1069–1075.
Kobayashi, M., and Yamamoto, M. 2006. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzyme Regulation 46:113–140.
Koop, D. R., and Casazza, J. P. 1985. Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. J. Biol. Chem. 260:13607–13612.
Kostrubsky, V. E., Szakacs, J. G., Jeffery, E. H., Wood, S. G., Bement, W. J., Wrighton, S. A., Sinclair, P. R., and Sinclair, J. F. 1997. Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity. Toxicol. Appl. Pharmacol. 143:315–323.
Koup, J. R., Anderson, G. D., and Loi, C. M. 1998. Effect of troglitazone on urinary excretion of 6beta-hydroxycortisol. J. Clin. Pharmacol. 38:815–818.
Krey, G., Braissant, O., L'Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., and Wahli, W. 1997. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11:779–791.
Kwak, M.-K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M., and Kensler, T. W. 2003. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1–Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem. 278:8135–8145.
LeClusye, E., Madan, A., Hamilton, G., Carroll, K., DeHaan, R., and Parkinson, A. 2000. Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. J. Biochem. Mol. Toxicol. 14:177–188.
Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., and Kliewer, S. A. 1998. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102:1016–1023.
Loi, C. M., Young, M., Randinitis, E., Vassos, A. B., and Koup, J. R. 1999. Clinical pharmacokinetics of troglitazone. Clin. Pharmacokinet. 37:91–104.
Luo, G., Cunningham, M., Kim, S., Burn, T., Lin, J., Sinz, M., Hamilton, G., Rizzo, C., Jolley, S., Gilbert, D., Downey, A., Mudra, D., Graham, R., Carroll, K., Xie, J., Madan, A., Parkinson, A., Christ, D., Selling, B., LeCluyse, E., and Gan, L.-S. 2002. CYP3A4 induction by drugs: Correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab. Dispos. 30:795–804.
Ma, X., Shah, Y., Cheung, C., Guo, G. L., Feigenbaum, L., Krausz, K. W., Idle, J. R., and Gonzalez, F. J. 2007. The pregnane X receptor gene-humanized mouse: A model for investigating drug–drug interactions mediated by cytochromes P450 3A. Drug Metab. Dispos. 35:194–200.
Maglich, J. M., Parks, D. J., Moore, L. B., Collins, J. L., Goodwin, B., Billin, A. N., Stoltz, C. A., Kliewer, S. A., Lambert, M. H., Willson, T. M., and Moore, J. T. 2003. Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J. Biol. Chem. 278:17277–17283.
Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., and Kliewer, S. A. 2002. Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol. Pharmacol. 62:638–646.
Maglich, J. M., Watson, J., McMillen, P. J., Goodwin, B., Willson, T. M., and Moore, J. T. 2004. The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J. Biol. Chem. 279:19832–19838.
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., and Mangelsdorf, D. J. 2002. Vitamin D receptor as an intestinal bile acid sensor. Science 296:1313–1316.
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., and Shan, B. 1999. Identification of a nuclear receptor for bile acids. Science 284:1362–1365.
Marlowe, J. L., and Puga, A. 2005. Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J. Cell. Biochem. 96:1174–1184.
Masubuchi, Y. 2006. Metabolic and nonmetabolic factors determining troglitazone hepatotoxicity: A review. Drug Metab. Pharmacokinet. 21:347–356.
McClain, C. J., Kromhout, J. P., Peterson, F. J., and Holtzman, J. L. 1980. Potentiation of acetaminophen hepatotoxicity by alcohol. JAMA 244:251–253.
McMillan, B. J., and Bradfield, C. A. 2007. The aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proc. Natl. Acad. Sci. USA 104:1412–1417.
Miller, E. C., Miller, J. A., and Hartmann, H. A. 1961. N-hydroxy-2-acetylaminofluorene: a metabolite of 2-acetylaminofluorene with increased carcinogenic activity in the rat. Cancer Res. 21:815–824.
Mills, J. B., Rose, K. A., Sadagopan, N., Sahi, J., and de Morais, S. M. F. 2004. Induction of drug metabolism enzymes and MDR1 using a novel human hepatocyte cell line. J. Pharmacol. Exp. Ther. 309:303–309.
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Davis, D. C., Gillette, J. R., and Brodie, B. B. 1973. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187:185–194.
Moore, L. B., Parks, D. J., Jones, S. A., Bledsoe, R. K., Consler, T. G., Stimmel, J. B., Goodwin, B., Liddle, C., Blanchard, S. G., Willson, T. M., Collins, J. L., and Kliewer, S. A. 2000. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 275:15122–15127.
Nebert, D. W. 1989. The Ah locus: Genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 20:153–174.
Nebert, D. W., Dalton, T. P., Okey, A. B., and Gonzalez, F. J. 2004. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279:23847–23850.
Nguyen, T., Yang, C. S., and Pickett, C. B. 2004. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Rad. Biol. Med. 37:433–441.
Niwa, A., Kumaki, K., Nebert, D.W., and Poland, A. P. 1975. Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse. Distinction between the “responsive” homozygote and heterozygote at the Ah locus. Arch. Biochem. Biophys. 166:559–564.
Omura, T., and Sato, R. 1962. A new cytochrome in liver microsomes. J. Biol. Chem. 237:PC1375–1376.
Park, B. K., Kitteringham, N. R., Maggs, J. L., Pirmohamed, M., and Williams, D. P. 2005. The role of metabolic activation in drug-induced hepatotoxicity. Ann. Rev. Pharmacol. Toxicol. 45:177–202.
Parkinson, A., and Hurwitz, A. 1991. Omeprazole and the induction of human cytochrome P-450: a response to concerns about potential adverse effects. Gastroenterology 100:1157–1164.
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., and Lehmann, J. M. 1999. Bile acids: Natural ligands for an orphan nuclear receptor. Science 284:1365–1368.
Pasanen, M., Pellinen, P., Stenback, F., Juvonen, R. O., Raunio, H., and Pelkonen, O. 1995. The role of CYP enzymes in cocaine-induced liver damage. Arch. Toxicol. 69:287–290.
Peet, D. J., Turley, S. D., Ma, W., Janowski, B. A., Lobaccaro, J.-M. A., Hammer, R. E., and Mangelsdorf, D. J. 1998. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR[alpha]. Cell 93:693–704.
Poland, A., Glover, E., and Kende, E.S. 1976. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-doxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J. Biol. Chem. 251:4936–4946.
Poso, A., and Honkakoski, P. 2006. Ligand recognition by drug-activated nuclear receptors PXR and CAR: structural, site-directed mutagenesis and molecular modeling studies. Mini-Rev. Med. Chem. 6:937–943.
Rae, J. M., Johnson, M. D., Lippman, M. E., and Flockhart, D. A. 2001. Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: Studies with cDNA and oligonucleotide expression arrays. J. Pharmacol. Exp. Ther. 299:849–857.
Ramachandran, V., Kostrubsky, V. E., Komoroski, B. J., Zhang, S., Dorko, K., Esplen, J. E., Strom, S. C., and Venkataramanan, R. 1999. Troglitazone increases cytochrome P-450 3A protein and activity in primary cultures of human hepatocytes. Drug Metab. Dispos. 27:1194–1199.
Ramos-Gomez, M., Kwak, M.-K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., and Kensler, T. W. 2001. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. USA 98:3410–3415.
Rangasamy, T., Cho, C. Y., Thimmulappa, R. K., Zhen, L., Srisuma, S. S., Kensler, T. W., Yamamoto, M., Petrache, I., Tuder, R. M., and Biswal, S. 2004. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 114:1248–1259.
Raucy, J. L., Lasker, J. M., Lieber, C. S., and Black, M. 1989. Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch. Biochem. Biophys 271:270–283.
Rencurel, F., Foretz, M., Kaufmann, M. R., Stroka, D., Looser, R., Leclerc, I., da Silva Xavier, G., Rutter, G. A., Viollet, B., and Meyer, U. A. 2006. Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver. Mol. Pharmacol. 70:1925–1934.
Reschly, E. J., and Krasowski, M. D. 2006. Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. Curr. Drug Metab. 7:349–365.
Riddick, D. S., Lee, C., Bhathena, A., and Timsit, Y. E. 2003. The 2001Veylien Henderson Award of the Society of Toxicology of Canada. Positive and negative transcriptional regulation of cytochromes P450 by polycyclic aromatic hydrocarbons. Can. J. Physiol. Pharmacol. 81:59–77.
Rifkind, A. B. 2006. CYP1A in TCDD toxicity and in physiology – with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates. Drug Metab. Rev. 38:291–335.
Ripp, S. L., Mills, J. B., Fahmi, O. A., Trevena, K. A., Liras, J. L., Maurer, T. S., and de Morais, S. M. 2006. Use of immortalized human hepatocytes to predict the magnitude of clinical drug–drug interactions caused by CYP3A4 induction. Drug Metab. Dispos. 34:1742–1748.
Rosenfeld, J. M., Vargas, R, Jr., Xie, W., and Evans, R. M 2003. Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol Endocrinol 17:1268–1282.
Sagredo, C., Ovrebo, S., Haugen, A., Fujii-Kuriyama, Y., Baera, R., Botnen, I. V., and Mollerup, S. 2006. Quantitative analysis of benzo[a]pyrene biotransformation and adduct formation in Ahr knockout mice. Toxicol. Lett. 167:173–182.
Sahi, J., Black, C. B., Hamilton, G. A., Zheng, X., Jolley, S., Rose, K. A., Gilbert, D., LeCluyse, E. L., and Sinz, M. W. 2003. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition. Drug Metab. Dispos. 31:439–446.
Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y., and Ishikawa, T. 2000. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 97:779–782.
Sims, P., Grover, P. L., Swaisland, A., Pal, K., and Hewer, A. 1974. Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide. Nature 252:326–328.
Sinz, M. W., Kim, S., Zhu, Z., Chen, T., Anthony, M., Dickinson, K., and Rodrigues, A. D. 2006. Evaluation of 170 xenobiotics as transactivators of human pregnane X receptor (hPXR) and correlation to known CYP3A4 drug interactions. Curr. Drug Metab. 7:375–388.
Sladek, N. E., and Mannering, G. J. 1966. Evidence for a new P-450hemoprotein in hepatic microsomes from methylcholanthrene treated rats. Biochem. Biophys. Res. Commun. 24:668–674.
Smith, M. T. 2003. Mechanisms of troglitazone hepatotoxicity. Chem. Res. Toxicol. 16:679–687.
Smith, D. A., Dickins, M., Fahmi, O. A,, Iwasaki, K., Lee, C., Obach, R. S., Padbury, G., de Morais, S. M., Ripp, S. L., Stevens, J., Voorman, R., and Youdim, K. 2007. The time to move cytochrome P450 induction into mainstream pharmacology is long overdue. Drug Metab. Dispos. 35:697–698.
Song, B.J., Matsunaga, T., Harwick, J.P., Park, S.S., Veech, R.L., Yang, C.S., Gelboin, H.V., and Gonzalez, F.G. 1987. Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat. Mol. Endocrinol. 1:542–547.
Song, B. J., Veech, R. L., Park, S. S., Gelboin, H. V., and Gonzalez, F. J. 1989. Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization. J. Biol. Chem. 264:3568–3572.
Sonoda, J., Chong, L. W., Downes, M., Barish, G. D., Coulter, S., Liddle, C., Lee, C.-H., and Evans, R. M. 2005. Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites. Proc. Natl. Acad. Sci. USA 102:2198–2203.
Squires, E. J., Sueyoshi, T., and Negishi, M. 2004. Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver. J. Biol. Chem. 279:49307–49314.
Stanley, L. A, Horsburgh, B. C., Ross, J., Scheer, N., and Wolf, C. R. 2006. PXR and CAR: Nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab. Rev. 38:515–597.
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., Willson, T. M., Koller, B. H., and Kliewer, S. A. 2001. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. USA 98:3369–3374.
Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P., and Negishi, M. 1999. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem. 274:6043–6046.
Synold, T. W., Dussault, I., and Forman, B. M. 2001. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat. Med. 7:584–590.
Teschke, R., Stutz, G., and Strohmeyer, G. 1979. Increased paracetamol-induced hepatotoxicity after chronic alcohol consumption. Biochem. Biophys. Res. Commun. 91:368–374.
Tettey, J. N., Maggs, J. L., Rapeport, W. G., Pirmohamed, M., and Park, B. K. 2001. Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo. Chem. Res. Toxicol. 14:965–974.
Thimmulappa, R. K., Mai, K. H., Srisuma, S., Kensler, T. W., Yamamoto, M., and Biswal, S. 2002. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62:5196–5203.
Thummel, K. E., Brimer, C., Yasuda, K., Thottassery, J., Senn, T., Lin, Y., Ishizuka, H., Kharasch, E., Schuetz, J., and Schuetz, E. 2001. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. Mol. Pharmacol. 60:1399–1406.
Thummel, K. E., Lee, C. A., Kunze, K. L,, Nelson, S. D., and Slattery, J. T. 1993. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem. Pharmacol. 45:1563–1569.
Truong, N.T., Moncion, S., Barouki, R., Beaune, P., and de Waziers, I. 2005. Regulatory sequence responsible for insulin destabilization of cytochrome P450 2B1 (CYP2B1) mRNA. Biochem. J. 388:227–235.
Tsuneoka, Y., Dalton, T. P., Miller, M. L., Clay, C. D., Shertzer, H. G., Talaska, G., Medvedovic, M., and Nebert, D. W. 2003. 4-Aminobiphenyl-induced liver and urinary bladder DNA adduct formation in Cyp1a2(–/–) and Cyp1a2(+/+) mice. J. Natl. Cancer Inst. 95:1227–1237.
Tzameli, I., Pissios, P., Schuetz, E. G., and Moore, D. D. 2000. The xenobiotic compound 1,4- bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol. Cell. Biol. 20:2951–2958.
Ueda, A., Hamadeh, H. K., Webb, H. K., Yamamoto, Y., Sueyoshi, T., Afshari, C. A., Lehmann, J. M., and Negishi, M. 2002. Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol. Pharmacol. 61:1–6.
Uno, S., Dalton, T. P., Derkenne, S., Curran, C. P., Miller, M. L., Shertzer, H. G., and Nebert, D. W. 2004. Oral exposure to benzo[a]pyrene in the mouse: Detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol. Pharmacol. 65:1225–1237.
Uno, S., Dalton, T. P., Dragin, N., Curran, C. P., Derkenne, S., Miller, M. L., Shertzer, H. G., Gonzalez, F. J., and Nebert, D. W. 2006. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate. Mol. Pharmacol. 69:1103–1114.
Venugopal, R., and Jaiswal Anil, K. 1996. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. USA 93:14960–14965.
Wei, P., Zhang, J., Dowhan, D. H., Han, Y., and Moore, D. D. 2002. Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J. 2:117–126.
Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., and Moore, D. D. 2000. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407:920–923.
Xie, W., Barwick, J. L., Downes, M., Blumberg, B., Simon, C. M., Nelson, M. C., Neuschwander-Tetri, B. A., Brunt, E. M., Guzelian, P. S., and Evans, R. M. 2000. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 406:435–439.
Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., and Evans, R. M. 2001. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc. Natl. Acad. Sci. USA 98:3375–3380.
Yamazaki, H., Shibata, A., Suzuki, M., Nakajima, M., Shimada, N., Guengerich, F. P., and Yokoi, T. 1999. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes. Drug Metab. Dispos. 27:1260–1266.
Yu, R., Lei, W., Mandlekar, S., Weber, M. J., Der, C. J., Wu, J., and Kong, A. N. T. 1999. Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem. 274:27545–27552.
Zhang, D. D. 2006. Mechanistic studies of the Nrf2–Keap1 signaling pathway. Drug Metab. Rev. 38:769–789.
Zhang, D. D., and Hannink, M. 2003. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23:8137–8151.
Zhang, J., Huang, W., Chua, S. S., Wei, P., and Moore, D. D. 2002. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 298:422–424.
Zhou, C., Poulton, E.-J., Grun, F., Bammler, T. K., Blumberg, B., Thummel, K. E., and Eaton, D. L. 2007 The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor. Mol Pharmacol 71:220–229.
Zimmerman, H. J., and Maddrey, W. C. 1995 Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure. Hepatology 22:767–773.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Ripp, S.L. (2008). Induction of Drug-Metabolizing Enzymes: Contrasting Roles in Detoxification and Bioactivation of Drugs and Xenobiotics. In: Elfarra, A. (eds) Advances in Bioactivation Research. Biotechnology: Pharmaceutical Aspects, vol IX. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77300-1_4
Download citation
DOI: https://doi.org/10.1007/978-0-387-77300-1_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-77299-8
Online ISBN: 978-0-387-77300-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)